Michael A Daneshvar
Overview
Explore the profile of Michael A Daneshvar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
78
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Leyderman M, Chandrasekar T, Grivas P, Li R, Bhat S, Basnet A, et al.
Nat Rev Urol
. 2024 Nov;
PMID: 39567681
Non-muscle-invasive bladder cancer (NMIBC) is the most common type of bladder cancer presentation and is characterized by a varying probability of recurrence and progression. Sporadically, patients with NMIBC might also...
2.
Hurwitz L, Bailey-Whyte M, Daneshvar M, Vocke C, Custer J, Ryan B, et al.
Cancer Causes Control
. 2024 Oct;
36(2):101-106.
PMID: 39390262
Purpose: Surgery, an established short-term immunosuppressive event, may spur dissemination of circulating tumor cells and promote the growth of micrometastases. Whether surgical treatment for prostate cancer (i.e., radical prostatectomy) leads...
3.
Hoyt M, Wang A, Ceja R, Cheavens J, Daneshvar M, Feldman D, et al.
Ann Behav Med
. 2023 Apr;
57(9):777-786.
PMID: 37078969
Background: Young adult testicular cancer survivors experience adverse impacts after treatment. We developed Goal-focused Emotion-regulation Therapy (GET) to improve distress symptoms, emotion regulation, and goal navigation skills. Purpose: This pilot...
4.
Williams C, Ahdoot M, Daneshvar M, Hague C, Wilbur A, Gomella P, et al.
J Urol
. 2021 Oct;
207(1):106-107.
PMID: 34633213
No abstract available.
5.
Bhambhvani H, Daneshvar M, Peterson D, Ball M
Int Urol Nephrol
. 2021 Oct;
53(12):2485-2492.
PMID: 34623590
Purpose: The literature assessing outcomes of partial adrenalectomy (PA) among patients with pheochromocytoma patients is largely limited to isolated, single-institution series. We aimed to perform a population-level comparison of outcomes...
6.
Williams C, Ahdoot M, Daneshvar M, Hague C, Wilbur A, Gomella P, et al.
J Urol
. 2021 Aug;
207(1):95-107.
PMID: 34433302
Purpose: Multiple studies demonstrate magnetic resonance imaging (MRI)-targeted biopsy detects more clinically significant cancer than systematic biopsy; however, some clinically significant cancers are detected by systematic biopsy only. While these...
7.
8.
Williams C, Khondakar N, Daneshvar M, OConnor L, Gomella P, Mehralivand S, et al.
J Urol
. 2021 Jun;
206(5):1157-1165.
PMID: 34181465
Purpose: We sought to evaluate whether bilateral prostate cancer detected at active surveillance (AS) enrollment is associated with progression to Grade Group (GG) ≥2 and to compare the efficacy of...
9.
Ahdoot M, Lebastchi A, Long L, Wilbur A, Gomella P, Mehralivand S, et al.
Eur Urol Oncol
. 2021 Apr;
5(2):176-186.
PMID: 33846112
Background: While magnetic resonance imaging (MRI)-targeted biopsy (TBx) results in better prostate cancer (PCa) detection relative to systematic biopsy (SBx), the combination of both methods increases clinically significant PCa detection...
10.
Bloom J, Daneshvar M, Lebastchi A, Ahdoot M, Gold S, Hale G, et al.
Urol Oncol
. 2021 Mar;
39(10):729.e1-729.e6.
PMID: 33736975
Purpose: Men with intermediate risk (IR) prostate cancer (CaP) are often excluded from active surveillance (AS) due to higher rates of adverse pathology (AP). We determined our rate of AP...